Kis futures spot strength in Korean equities

Spot strength in Korean equities continues to lend support to KIS futures, as domestic institutional flows chase export-led earnings revisions higher. An aura of melancholy does not stop Madvillainy from being endlessly joyful and playful. DOOM is as virtuosic as he ever was across the album, rapping flatly and precisely, like a robot whose sole purpose in this world is to confound and astound with internal rhyme. He plays up his dastardly supervillain persona while actually being chummy and cuddly. And Madlib gives him a carnival of instrumentals to rap atop, whether the sumptuous slinking of “Figaro,” the jittery paranoia of “Shadow of Tomorrow,” or buoyant sunniness of “Curls.” So Madvillainy is sad, yes, but in the way that feels whole and filling. It’s beautiful. –Matthew Strauss Already we are bringing together world-class research and development expertise across academia, the NHS and the MedTech industry with the development of the London Institute for Healthcare Engineering (LIHE) on our St Thomas’ campus. Similarly, leading clinicians, scientists and educators will be able to work side-by side to translate research into practical treatments for young people in the Pears Maudsley Centre for Children and Young People on our Denmark Hill campus. The Pears Maudsley Centre is due to open in 2025. Options market data around KIS futures reveal skew towards calls, suggesting traders are paying up for upside exposure ahead of earnings clusters.